8-K: Ryan Specialty Q3 Revenue Jumps 24.8% Amid Strong Organic Growth

Ryan Specialty Holdings, Inc. announced robust third-quarter 2025 results, with total revenue growing 24.8% year-over-year and organic revenue up 15.0%, alongside a declared quarterly dividend.

Summary

• Total Revenue for the third quarter of 2025 increased 24.8% year-over-year to $754.6 million.
• Organic Revenue Growth Rate was 15.0% for the quarter, compared to 11.8% in the prior-year period.
• Net Income for the third quarter of 2025 increased 118.6% year-over-year to $62.6 million.
• Diluted Earnings Per Share was $0.20 for the third quarter of 2025.
• Adjusted EBITDAC grew 23.8% year-over-year to $235.5 million.
• Adjusted Net Income increased 15.9% year-over-year to $131.7 million.
• Adjusted Diluted Earnings Per Share grew 14.6% to $0.47.
• A regular quarterly dividend of $0.12 per share on the outstanding Class A common stock was declared.
• Full year 2025 guidance for Organic Revenue Growth Rate is double digits.
• Full year 2025 guidance for Adjusted EBITDAC Margin is flat to modestly down compared to the prior year, due to strategic investments in talent and technology.

Sentiment

Score: 8

Explanation: The company delivered strong Q3 financial results with significant revenue and net income growth, robust organic expansion, and a declared dividend. While Adjusted EBITDAC margin saw a slight dip and full-year guidance for this metric was revised to 'flat to modestly down' due to strategic investments, the overall performance and management's confidence in future growth opportunities are positive.

Positives

• Total revenue grew 24.8% year-over-year to $754.6 million, demonstrating strong top-line expansion.
• Organic Revenue Growth Rate was robust at 15.0%, indicating healthy underlying business performance and market penetration.
• Net Income increased significantly by 118.6% year-over-year to $62.6 million, reflecting improved profitability.
• Adjusted EBITDAC grew 23.8% to $235.5 million, showcasing strong operational earnings.
• Adjusted Net Income increased 15.9% to $131.7 million, and Adjusted Diluted Earnings Per Share grew 14.6% to $0.47.
• Experienced growth across the majority of casualty lines and modest growth in property lines across all three specialties.
• Declared a regular quarterly dividend of $0.12 per share, signaling confidence in future cash flows and commitment to shareholder returns.
• Completion of the ACCELERATE 2025 program resulted in decreased restructuring and related expenses.

Negatives

• Adjusted EBITDAC Margin slightly decreased to 31.2% from 31.5% in the prior-year period.
• Adjusted Net Income Margin decreased to 17.5% from 18.8% in the prior-year period.
• General and administrative expense ratio increased to 15.6% from 14.7% in the prior-year period.
• Higher Interest expense, net, at $56.3 million compared to $49.4 million in the prior-year period.
• Lower Income tax benefit compared to the prior-year period.
• Net income for the nine months ended September 30, 2025, decreased by 2.4% to $182.9 million compared to $187.4 million in the prior-year period.
• Net income attributable to Ryan Specialty Holdings, Inc. for the nine months ended September 30, 2025, decreased by 31.5% to $55.4 million compared to $80.9 million in the prior-year period.
• Full year 2025 guidance for Adjusted EBITDAC Margin is 'flat to modestly down,' indicating potential margin compression due to strategic investments.

Risks

• Forward-looking statements involve substantial risks and uncertainties, and actual results may differ materially from expectations.
• Ability to achieve the associated objectives with its Program may not materialize as expected.
• Costs and charges associated with restructuring initiatives may exceed current estimates and forecasts.
• Ability to realize expected savings and benefits in the amounts and at the times anticipated may be impacted.
• Changes in management's assumptions could affect future performance.
• Ability to achieve anticipated financial results is subject to various factors.
• Risks are associated with acquisitions, divestitures, joint ventures, and strategic investments.
• Outcomes of legal and regulatory matters could negatively impact the company.
• Changes in legislation or regulations may affect operations and financial condition.
• Inherent difficulty exists in forecasting the timing of items and quantifying certain amounts necessary for reconciliation of non-GAAP measures, including variations in effective tax rate, acquisition expenses, and other one-time or exceptional items.

Future Outlook

The company updated its full year 2025 guidance, projecting an Organic Revenue Growth Rate of double digits. The Adjusted EBITDAC Margin for the full year 2025 is guided to be flat to modestly down compared to the prior year. This revised guidance for Adjusted EBITDAC Margin reflects a significantly increased and unpredictable opportunity to hire broking and underwriting talent and to make other investments in the business, which is anticipated to persist for at least the near term.

Management Comments

• Patrick G. Ryan, Founder and Executive Chairman: "It was a strong quarter for Ryan Specialty, demonstrating the strength and resilience of our firm throughout a challenging insurance and macro environment. We grew total revenue 25%, supported by strong organic growth of 15%, and another quarter of excellent contributions from our recent M&A transactions. We grew Adjusted EBITDAC 23.8% and Adjusted Diluted EPS by 14.6%. I am especially proud of what weve achieved while making substantial strategic investments during the quarter to capitalize on excellent opportunities to add broking and underwriting talent to our world-class team, as well as making continued investments in technology. We are well positioned to strengthen our position as an international leader in the specialty lines industry for years to come."
• Timothy W. Turner, Chief Executive Officer: "Our teams relentless execution this quarter underscores the power of our platform, the depth of our expertise, and our unwavering commitment to serving our clients and trading partners. We are navigating this challenging and transitioning market with confidence, driven by our diverse product offerings, durable business model, and a culture that continues to attract talented professionals. The runway ahead of us is significant, and we remain focused on delivering industry-leading organic growth and long-term value for our shareholders."

Industry Context

The company operates within the specialty insurance and Excess & Surplus (E&S) markets, which management describes as a "challenging insurance and macro environment." Despite these challenges, the firm demonstrated resilience and strong growth, particularly in casualty lines. The strategic investments in broking and underwriting talent, along with technology, indicate a proactive approach to capitalize on market opportunities and strengthen its position as an international leader in specialty lines, suggesting a focus on expanding market share and capabilities within a competitive landscape.

Stakeholder Impact

• Shareholders are positively impacted by strong financial performance, significant increases in net income and adjusted diluted EPS, and the declaration of a regular quarterly dividend, indicating a commitment to shareholder returns and potential for long-term value creation.
• Employees may see positive impacts from the company's strategic investments in adding broking and underwriting talent, suggesting growth opportunities and a focus on strengthening the team.
• Clients and trading partners benefit from the company's unwavering commitment to serving them, underscored by its diverse product offerings, depth of expertise, and continued investments in technology and talent.

Next Steps

• Payment of the regular quarterly dividend on November 25, 2025, to stockholders of record as of November 11, 2025.
• Continued strategic investments in broking and underwriting talent to capitalize on market opportunities.
• Ongoing investments in technology to enhance platform capabilities.
• Focus on delivering industry-leading organic growth and long-term value for shareholders.

Key Dates

Recommendation

The company demonstrated strong financial performance in Q3 2025 with significant revenue and organic growth, indicating robust business momentum in a challenging market. The substantial increase in net income and adjusted diluted EPS, coupled with a consistent quarterly dividend, suggests healthy profitability and a commitment to shareholder returns. While the Adjusted EBITDAC margin guidance for the full year is flat to modestly down due to strategic investments, these investments in talent and technology are crucial for long-term competitive advantage and future growth, positioning the company well as an international leader in specialty lines. The overall outlook remains positive, supporting a 'buy' recommendation for long-term investors.

Keywords

Specialty insurance, Wholesale brokerage, Underwriting management, Organic growth, Q3 2025 results, RYAN, Dividend, Adjusted EBITDAC, Adjusted Net Income, E&S market